Patent foramen ovale and migraine

Current Pain and Headache Reports

Volumn 11, Issue 3, 2007, Pages 236-240

  Diener, Hans Christoph ^a   Kurth, Tobias ^b   Dodick, David ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; LAMOTRIGINE; TOPIRAMATE;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT LEFT SHUNT; HEART SURGERY; HEART TAMPONADE; HEREDITY; HUMAN; LUNG ARTERIOVENOUS SHUNT; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; OBSERVATIONAL STUDY; PERICARDIAL EFFUSION; RETROPERITONEAL HEMORRHAGE; REVIEW; RISK FACTOR; SURGICAL APPROACH; SURGICAL EQUIPMENT; THORAX PAIN; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MIGRAINE DISORDERS;

EID: 34249812977     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-007-0196-2     Document Type: Review

References (35)

1. Del Sette M, Angeli S, Leandri M, et al.: Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998, 8:327-330.
2. Anzola GP, Magoni M, Guindani M, et al.: Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999, 52:1622-1625.
3. Dalla Volta G, Guindani M, Zavarise P, et al.: Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 2005, 6:328-330.
4. Schwerzmann M, Nedeltchev K, Lagger F, et al.: Prevalence and size of directly detected parent foramen ovale in migraine with aura. Neurology 2005, 65:1415-1418.
5. Carod-Artal FJ, da Silveira Ribeiro L, Braga H, et al.: Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 2006, 26:934-939.
6. Wammes-van der Heijden EA, Rahimtoola H, Leufkens HG, et al.: Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 2006, 67:1128-1134.
7. Schwedt TJ, Dodick DW: Patent foramen ovale and migraine--bringing closure to the subject. Headache 2006, 46:663-671.
8. Bousser MG: Patent foramen ovale and migraine: evidence for a link? Headache Currents 2006, 3:44-51.
9. Wilmshurst PT, Pearson MJ, Nightingale S, et al.: Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004, 90:1315-1320.
10. Moussouttas M, Fayad P, Rosenblatt M, et al.: Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 2000, 55:959-964.
11. White RI Jr, Lynch-Nyhan A, Terry P, et al.: Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988, 169:663-669.
12. Mortelmans K, Post M, Thijs V, et al.: The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 2005, 26:1533-1537.
13. Sztajzel R, Genoud D, Roth S, et al.: Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002, 13:102-106.
14. Lamy C, Giannesini C, Zuber M, et al.: Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke 2002, 33:706-711.
15. Venketasubramanian N, Sacco RL, Di Tullio M, et al.: Vascular distribution of paradoxical emboli by transcranial Doppler. Neurology 1993, 43:1533-1535.
16. Crassard I, Conard J, Bousser MG: Migraine and haemostasis. Cephalalgia 2001, 21:630-636.
17. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL: Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005, 91:1173-1175.
18. Riederer F, Kaya M, Christina P, et al.: Migraine with aura related to closure of atrial septal defects. Headache 2005, 45:953-956.
19. Steele JG, Nath PU, Burn J, Porteous ME: An association between migrainous aura and hereditary haemorrhagic telangiectasia. Headache 1993, 33:145-148.
20. Dowson AJ, Wilmshurst P, Muir KW, et al.: A prospective, multicenter, randomized, double blind, placebo-controlled trial to evaluate the efficacy of patent foramen ovale closure with the STARFlex septal repair implant to prevent refractory migraine headaches: the MIST trial. Neurology 2006, 67:185.
21. Lampl C, Bonelli S, Ransmayr G: Efficacy of topiramate in migraine aura prophylaxis: preliminary results of 12 patients. Headache 2004, 44:174-177.
22. Lampl C, Katsarava Z, Diener HC, Limmroth V: Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 2005, 76:1730-1732.
23. Schwerzmann M, Wiher S, Nedeltchev K, et al.: Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004, 62:1399-1401.
24. Post M, Thijs V, Herroelen L, Budts W: Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004, 62:1439-1440.
25. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL: Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000, 356:1648-1651.
26. Reisman M, Christofferson RD, Jesurum J, et al.: Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005, 45:493-495.
27. Azarbal B, Tobis J, Suh W, et al.: Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 2005, 45:489-492.
28. Buring JE, Peto R, Hennekens CH: Low-dose aspirin for migraine prophylaxis. JAMA 1990, 264:1711-1713.
29. Diener HC, Hartung E, Chrubasik J, et al.: A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia 2001, 21:120-128.
30. Bensenor IM, Cook NR, Lee IM, et al.: Low-dose aspirin for migraine prophylaxis in women. Cephalalgia 2001, 21:175-183.
31. Sharifi M, Burks J: Efficacy of clopidogrel in the treatment of post-ASD closure migraines. Catheter Cardiovasc Interv 2004, 63:255.
32. Lapergue B, Rosso C, Hadrane L, et al.: Frequency of migraine attacks following stroke starts to decrease before PFO closure. Neurology 2006, 67:1099-1100.
33. Wilmshurst P, Nightingale S: Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001, 100:215-220.
34. Morandi E, Anzola GP, Angeli S, et al.: Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003, 16:39-42.
35. Giardini A, Donti A, Formigari R, et al.: Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke. Catheter Cardiovasc Interv 2006, 67:625-629.